Hansen Pharmaceutical's Simotang Oral Liquid and Two Other Products Newly Included in National Essential Medicines List

Regulation
โดย Jiemian·Read original
Summary · why it matters

Hunan Hansen Pharmaceutical Co., Ltd. announced that three of its products—Simotang Oral Liquid, Dextromethorphan Granules, and Empagliflozin Tablets—have been newly included in the National Essential Medicines List (2026 Edition), with Simotang Oral Liquid being an exclusive variety. The list will officially take effect on September 1, 2026. In addition, the company's existing products—Suoquan Capsules, Huoxiang Zhengqi Water, and Iohexol Injection—remain on the list.

Impact on stocks 1

Others · 1 stocks